FDA documents find that Gardasil, a human papilloma virus vaccine, may actually increase the risk of cervical cancer.

HealthDay News reports the drug is designed to block infection by four types of HPV that cause more cervical cancers and genital warts

Research has led to a vaccine for cervical cancer that protects against strains of the human papilloma virus (HPV).

HPV, according to BBC, is thought to be the most common cause of cervical cancer

Wolfsburg, home of the Volkswagen, is about to make a name for itself as a European pioneer in implementing better strategies for preventing cervical cancer. A local hospital, insurance company, and health organization are teaming up to reduce the number of cervical cancer patients.

The disease claims nearly 2,000 women's lives each year in Germany- while another 7,000 cases are diagnosed each year

GlaxoSmithKline Plc released results from a trial Saturday on a vaccine to prevent infection of the human papillomavirus in girls age 10 to 14.

The data suggests that the Cervarix vaccine provides the strongest and most-prolonged protection if its given to girls at young ages, before they even encounter sexually transmitted diseases, reports Reuters. The girls given the vaccine had immune responses twice as strong as women 15-25 years of age given Cervarix

Biological health care product provider CSL Ltd announces that a new vaccine developed by US pharmaceutical company Merck, based on CSL technology, has prevented high grade cervical pre-cancers and non-invasive cervical cancers, reports Asia Pulse.

CSL says that the Gardasil prevents the pre-cancers and non-invasive cervical cancers related to the human papillomavirus (HPV) types 16 and 18 that make up about 70 per cent of all cervical cancers